How do you identify and mitigate your biggest drug development risks? What decisions should you prioritize?
Balancing the various demands of a multi-disciplinary development program can be overwhelming, especially with tight deadlines and resources. There are numerous strategic options and decisions that you face where insightful input from experienced drug developers can increase probability of reaching your objectives.
Our R&D Program Leaders worldwide partner with clients to develop key decision criteria and help facilitate decision-making throughout your drug development program. They act as your thought partner and the single point of accountability, providing:
- Strategic guidance
- Stewardship
- Operational support
Strategic guidance to steer your program
We are accountable for the strategy and cross-functional alignment to execute complex, multi-disciplinary development programs with over-arching strategic support:
- Identify critical target product profile criteria to differentiate and increase potential commercial value
- Align business goals with program objectives
- Evaluate, design and identify alternative R&D strategies
Stewardship to deliver a seamless experience and support
We have extensive experience leading integrated, multi-disciplinary drug development teams with expert communication and management.
- Effectively manage and navigate across and between organizations
- Provide portfolio governance leadership and management
- Lead stakeholder management
Operational support to plan, anticipate and mitigate risk
- Ensure quality project delivery on time & to budget
- Identify risks and develop mitigation plans
- Forecast and plan scenarios
We also provide full project management capabilities with an expert team that works in tandem with our drug development stewards.
Yvonne has over 20+ years leading strategic design and operational delivery of new medicines and novel drug delivery device projects. She has worked on more than 100 successful global pharma regulatory submissions in respiratory, cardiovascular, oncology immunology, and orphan drug indications in both small molecules, orphan drugs and biologicals.
Colin works with pharmaceutical development teams to identify and deliver successful strategies and tactics to bring medicinal products to market. His 30-year professional background spans the R&D continuum and includes extensive cross-functional team leadership and project management experience with non-clinical, clinical, CMC and regulatory programs.
Yvonne has over 20+ years leading strategic design and operational delivery of new medicines and novel drug delivery device projects. She has worked on more than 100 successful global pharma regulatory submissions in respiratory, cardiovascular, oncology immunology, and orphan drug indications in both small molecules, orphan drugs and biologicals.
Colin works with pharmaceutical development teams to identify and deliver successful strategies and tactics to bring medicinal products to market. His 30-year professional background spans the R&D continuum and includes extensive cross-functional team leadership and project management experience with non-clinical, clinical, CMC and regulatory programs.
